VictoryShares Pioneer Asset-Based Income ETF (ABI) Stock Price

25.01 ▲ +0.015 (+0.06%)
Open: 25.01 Vol: 100 Day's range: 25.01 - 25.01 Feb 20, 16:00 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
ABI Technical Analysis
5 mins 30 mins Hourly Daily Weekly
NEUTRAL NEUTRAL NEUTRAL BUY BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 N/A     N/A     N/A     25.01▲ 25.03▼
MA10 N/A     N/A     N/A     25.00▲ 24.94▲
MA20 N/A     N/A     N/A     25.01▼ 24.93▲
MA50 N/A     N/A     N/A     24.92▲ N/A    
MA100 N/A     N/A     N/A     24.94▲ N/A    
MA200 N/A     N/A     N/A     N/A     N/A    
  5 mins 30 mins Hourly Daily Weekly
MACD N/A     N/A     N/A     -0.008▼ N/A    
RSI N/A     N/A     N/A     55.496▲ 53.450▲
STOCH N/A     N/A     N/A     36.884     84.711▲
WILL %R N/A     N/A     N/A     -69.231     -25.352    
CCI N/A     N/A     N/A     -20.121     74.808    
Latest Filters Detected On ABI
MA $ABI Price Crossed Above MA(7) Set Alert
CDL $ABI Doji Candlestick Pattern Detected Set Alert
VictoryShares Pioneer Asset-Based Income ETF News
Powerfleet Ranked by ABI Research as One of the 7 Most Innovative Global Tech Companies
Monday, July 21, 2025 04:59 AM
WOODCLIFF LAKE, N.J., July 21, 2025 /PRNewswire/ -- Powerfleet, Inc. (Nasdaq: AIOT), a global leader in the artificial intelligence of things (AIoT) software-as-a-service (SaaS) mobile asset industry, ...
Assembly Biosciences Reports Positive Phase 1b Results for ABI-4334 in Chronic HBV Infection, Supporting Collaboration with Gilead Sciences
Wednesday, June 25, 2025 05:11 AM
Assembly Biosciences reported positive Phase 1b results for ABI-4334 in chronic HBV, showing strong antiviral activity and favorable safety. Assembly Biosciences, Inc. has announced positive results ...
Assembly Biosciences Initiates Phase 1a Study Of ABI-6250, Oral Entry Inhibitor For
Wednesday, February 26, 2025 06:52 AM
(RTTNews) - Assembly Biosciences (ASMB), a biotechnology company focused on developing treatments for viral diseases, announced on Wednesday that the first participant has been dosed in its Phase 1a ...
ABI historical stock data
date open high low close volume
20/02/26 25.01 25.01 25.01 25.01 100
19/02/26 24.995 24.995 24.995 24.995 100
18/02/26 25.00 25.00 25.00 25.00 8
17/02/26 25.02 25.02 25.02 25.02 100
13/02/26 25.02 25.02 25.02 25.02 12
12/02/26 24.985 24.985 24.985 24.985 100
11/02/26 24.97 24.97 24.97 24.97 5
10/02/26 24.98 24.98 24.98 24.98 100
09/02/26 24.97 24.97 24.97 24.97 100
06/02/26 25.085 25.085 25.085 25.085 100
Quote Details
52wk Low:24.745
52wk High:25.36
Vol:100
Avg Vol(3m):20.7K
1Y Chng:+0.00%
1M Chng:+0.56%
Add to Watch List
More Information
Sector N/A
Index N/A
Market Cap. 0.00